Our recent findings that EPO directly stimulates bone loss via activation of EPO-R signaling in the monocytic lineage30, coupled with the central role of macrophages in MM32, highlight the need to determine EPO effect on bone in the context of MM. Here, EPO is linked to Miyoshi myopathy.